Here is the FDA’s list of potential risks: The FDA recommends those who need treatment get it at an accredited facility saying, “Explosions and fires have occurred in HBOT chambers that have ...

Adicet Bio (ACET) announced the FDA has granted fast track designation to ADI-001 for the potential treatment of adult patients with refractory ...

EssilorLuxottica said on Monday it received a green light from the U.S. Food and Drug Administration (FDA) for its ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. For the first time in over two decades, the U.S. Food and Drug Administration (FDA) has ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals. The drug, Journavx, or suzetrigine, was approved to treat moderate to severe ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. The new development is ...

Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in adults. Symbravo represents a novel multi-mechanistic ...

(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.

Democratic senators are expressing alarm about planned budget reallocations at the Food and Drug Administration that they fear will threaten the nation’s food safety system. In a letter to FDA ...

The development is expected to accelerate medical research, drug discovery, ... Google’s new quantum computer signals a potential end to the competition with traditional machines and promises ...